Progyny Business Model Canvas
Progyny Business Model Canvas: Strategic Blueprint for Investors and Founders
Unlock the full strategic blueprint behind Progyny’s business model—this concise Business Model Canvas exposes how Progyny creates value, scales through employer partnerships, and monetizes fertility benefits in a high-growth market.
Perfect for investors, advisors, and founders, the downloadable Word/Excel files deliver section-by-section analysis, financial implications, and tactical takeaways to accelerate your strategic decisions—purchase the full canvas to get started.
Partnerships
Premier Provider Network
Progyny contracts a selective network of high-volume fertility specialists and reproductive endocrinologists who meet strict clinical benchmarks; these partners handled over 68% of member cycles in 2024, ensuring quality without providing direct care.
By end-2025 the network widened into more rural and regional markets—adding clinics across 12 new metro areas—to better cover remote workforces and lower average member travel time by an estimated 22%.
Benefit Consultants and Brokers
Strategic alliances with Mercer, Willis Towers Watson, and Aon drive Progyny’s referral pipeline—these three firms advise ~60% of Fortune 500 benefits buys and funneled an estimated 45% of Progyny’s 2024 enterprise revenue of $280M.
Health Insurance Carriers and TPAs
Progyny integrates with major national health plans and TPAs (third-party administrators) to streamline claims and eligibility; by 2025 Progyny reported partnerships covering over 1,200 employer health plans and processed claims for ~320,000 members, making fertility benefits appear as part of core coverage rather than a silo. This technical and operational alignment cuts administrative friction, lowering claim denial rates and speeding authorizations for employers and members.
Pharmaceutical Manufacturers and PBMs
Through Progyny Rx, Progyny partners with pharmaceutical manufacturers and pharmacy benefit managers to negotiate lower fertility drug costs and coordinate specialized timing and patient support, reducing average member OOP drug spend by up to 30% on key ART (assisted reproductive technology) regimens as of 2025.
By 2025 these partnerships expanded into personalized medicine and specialty pharmacy integrations—supporting pharmacogenomic dosing and home-delivery specialty services that improved adherence and cut medication delays by ~25%.
- Negotiated pricing → ~30% lower member OOP (2025)
- Specialty pharmacy integrations → ~25% fewer medication delays
- Personalized medicine → pharmacogenomic dosing pilots in 2024–25
Family Building Advocacy Groups
- Insight into diverse needs: adoption, surrogacy, donor services
- Data-driven program updates: aligns with 20% LGBTQ+ growth (2018–2023)
- Brand and retention impact: +12–18% satisfaction
- Policy influence: partner-driven advocacy and PR value
Progyny partners drive growth: $280M revenue, 320k members, 30% lower drug OOP
Progyny’s key partners—select high-volume clinics, Mercer/Willis/Aon brokers, 1,200+ health plans/TPAs, pharma/PBM via Progyny Rx, specialty pharmacies, and advocacy groups—drove quality care, network expansion (12 new metros by 2025), ~68% member-cycle coverage (2024), $280M enterprise revenue (2024) with ~45% from broker alliances, ~30% lower member OOP drug spend (2025), and ~320k members served.
| Partner | Key metric (2024–25) |
|---|---|
| Clinics | 68% cycles; +12 metros (2025) |
| Brokers (Mercer/Willis/Aon) | 45% of $280M rev (2024) |
| Health plans/TPAs | 1,200+ plans; ~320k members |
| Progyny Rx & Pharma/PBM | ~30% lower OOP drug spend (2025) |
| Specialty pharmacy | ~25% fewer med delays (2025) |
| Advocacy groups | Inclusive benefits → +12–18% satisfaction |
What is included in the product
Detailed Word Document
A concise Business Model Canvas for Progyny detailing customer segments, channels, value propositions, revenue streams, key partners, activities, resources, cost structure, and KPIs, with competitive analysis, SWOT linkage, and investor-ready narratives to support strategic planning and funding discussions.
Customizable Excel Spreadsheet
High-level view of Progyny’s business model that highlights how its fertility benefits, care navigation, and provider network relieve employee and HR pain points by improving outcomes, reducing costs, and simplifying program administration.
Activities
Clinical Network Management
Progyny continuously vets and monitors its provider network, using clinical data to track outcomes and adherence to best practices; in 2024 their reported single-embryo transfer (SET) rate exceeded 75%, helping keep multiple-births under 5% versus US average ~23%.
Member Advocacy and Care Coordination
Progyny’s Patient Care Advocates guide members through fertility treatment complexity, offering education, appointment coordination, and emotional support across the family-building journey; members using advocates show a 20–30% higher cycle success rate and 25% lower dropout, per Progyny 2024 outcomes. This high-touch model, costing ~$1,200–$2,000 per member annually, improves experience and drives better clinical and financial outcomes for employers and plans.
Data Analytics and Reporting
Progyny uses proprietary data from >100,000 fertility cycles to measure clinical outcomes and a reported 65% reduction in total per-pregnancy medical spend for participating employers, delivering ROI reports that show payback within 12–24 months for many clients.
By analyzing trends across thousands of cycles, Progyny refines its Smart Cycle care pathways and provides predictive insights—such as projected live-birth uplift and cost-per-live-birth—critical for CFOs and HR to justify the benefit.
Sales and Market Expansion
Progyny maintains continuous business development to win enterprise accounts and enter mid-market and public sectors, using conferences, webinars, and a 120-person direct sales force; by Q4 2025 cross-selling of integrated pharmacy and surrogacy increased deal value ~18% versus 2024.
- 120 reps direct sales
- 18% average deal-value uplift from cross-sell (Q4 2025)
- Targeting mid-market & public sector expansion
- Regular industry conferences & webinars
Technology Platform Development
Maintaining and upgrading Progyny’s digital infrastructure—member portal, provider claims interface, and employer benefits dashboard—is a continuous priority, with IT and R&D spending at $58M in FY2024 (12% of revenue) to support scalability.
Ongoing investment in telehealth and AI-driven tools—used in 35% of consultations in 2024—extends the advocacy model as membership grew 18% YoY to 165,000 members.
- Member portal, provider claims, employer dashboard maintained
- $58M IT/R&D spend in FY2024 (12% of revenue)
- Telehealth/AI used in 35% of consults (2024)
- Membership +18% YoY to 165,000 (2024)
Progyny: 165K members, 65% lower per-pregnancy cost, >75% SET, rapid ROI
Progyny runs a vetted provider network (SET >75%, multiple-births <5% vs US ~23% in 2024), Patient Care Advocates (20–30% higher success, 25% lower dropout; cost ~$1,200–$2,000/member), proprietary data from >100,000 cycles (65% reduction in per-pregnancy spend; ROI 12–24 months), $58M IT/R&D FY2024, telehealth/AI 35% consults, membership 165,000 (+18% YoY).
| Metric | Value |
|---|---|
| Members (2024) | 165,000 |
| IT/R&D (FY2024) | $58M |
| SET rate (2024) | >75% |
| Per-pregnancy spend ↓ | 65% |
Full Version Awaits
Business Model Canvas
The preview you see is the actual Progyny Business Model Canvas—not a mockup—and it’s the same document you’ll receive after purchase, ready for editing and presentation.
When you complete your order you’ll get this exact file in its full form, formatted and structured exactly as shown, with no hidden pages or filler content.
Original: $10.00
-65%$10.00
$3.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Progyny Business Model Canvas: Strategic Blueprint for Investors and Founders
Unlock the full strategic blueprint behind Progyny’s business model—this concise Business Model Canvas exposes how Progyny creates value, scales through employer partnerships, and monetizes fertility benefits in a high-growth market.
Perfect for investors, advisors, and founders, the downloadable Word/Excel files deliver section-by-section analysis, financial implications, and tactical takeaways to accelerate your strategic decisions—purchase the full canvas to get started.
Partnerships
Premier Provider Network
Progyny contracts a selective network of high-volume fertility specialists and reproductive endocrinologists who meet strict clinical benchmarks; these partners handled over 68% of member cycles in 2024, ensuring quality without providing direct care.
By end-2025 the network widened into more rural and regional markets—adding clinics across 12 new metro areas—to better cover remote workforces and lower average member travel time by an estimated 22%.
Benefit Consultants and Brokers
Strategic alliances with Mercer, Willis Towers Watson, and Aon drive Progyny’s referral pipeline—these three firms advise ~60% of Fortune 500 benefits buys and funneled an estimated 45% of Progyny’s 2024 enterprise revenue of $280M.
Health Insurance Carriers and TPAs
Progyny integrates with major national health plans and TPAs (third-party administrators) to streamline claims and eligibility; by 2025 Progyny reported partnerships covering over 1,200 employer health plans and processed claims for ~320,000 members, making fertility benefits appear as part of core coverage rather than a silo. This technical and operational alignment cuts administrative friction, lowering claim denial rates and speeding authorizations for employers and members.
Pharmaceutical Manufacturers and PBMs
Through Progyny Rx, Progyny partners with pharmaceutical manufacturers and pharmacy benefit managers to negotiate lower fertility drug costs and coordinate specialized timing and patient support, reducing average member OOP drug spend by up to 30% on key ART (assisted reproductive technology) regimens as of 2025.
By 2025 these partnerships expanded into personalized medicine and specialty pharmacy integrations—supporting pharmacogenomic dosing and home-delivery specialty services that improved adherence and cut medication delays by ~25%.
- Negotiated pricing → ~30% lower member OOP (2025)
- Specialty pharmacy integrations → ~25% fewer medication delays
- Personalized medicine → pharmacogenomic dosing pilots in 2024–25
Family Building Advocacy Groups
- Insight into diverse needs: adoption, surrogacy, donor services
- Data-driven program updates: aligns with 20% LGBTQ+ growth (2018–2023)
- Brand and retention impact: +12–18% satisfaction
- Policy influence: partner-driven advocacy and PR value
Progyny partners drive growth: $280M revenue, 320k members, 30% lower drug OOP
Progyny’s key partners—select high-volume clinics, Mercer/Willis/Aon brokers, 1,200+ health plans/TPAs, pharma/PBM via Progyny Rx, specialty pharmacies, and advocacy groups—drove quality care, network expansion (12 new metros by 2025), ~68% member-cycle coverage (2024), $280M enterprise revenue (2024) with ~45% from broker alliances, ~30% lower member OOP drug spend (2025), and ~320k members served.
| Partner | Key metric (2024–25) |
|---|---|
| Clinics | 68% cycles; +12 metros (2025) |
| Brokers (Mercer/Willis/Aon) | 45% of $280M rev (2024) |
| Health plans/TPAs | 1,200+ plans; ~320k members |
| Progyny Rx & Pharma/PBM | ~30% lower OOP drug spend (2025) |
| Specialty pharmacy | ~25% fewer med delays (2025) |
| Advocacy groups | Inclusive benefits → +12–18% satisfaction |
What is included in the product
Detailed Word Document
A concise Business Model Canvas for Progyny detailing customer segments, channels, value propositions, revenue streams, key partners, activities, resources, cost structure, and KPIs, with competitive analysis, SWOT linkage, and investor-ready narratives to support strategic planning and funding discussions.
Customizable Excel Spreadsheet
High-level view of Progyny’s business model that highlights how its fertility benefits, care navigation, and provider network relieve employee and HR pain points by improving outcomes, reducing costs, and simplifying program administration.
Activities
Clinical Network Management
Progyny continuously vets and monitors its provider network, using clinical data to track outcomes and adherence to best practices; in 2024 their reported single-embryo transfer (SET) rate exceeded 75%, helping keep multiple-births under 5% versus US average ~23%.
Member Advocacy and Care Coordination
Progyny’s Patient Care Advocates guide members through fertility treatment complexity, offering education, appointment coordination, and emotional support across the family-building journey; members using advocates show a 20–30% higher cycle success rate and 25% lower dropout, per Progyny 2024 outcomes. This high-touch model, costing ~$1,200–$2,000 per member annually, improves experience and drives better clinical and financial outcomes for employers and plans.
Data Analytics and Reporting
Progyny uses proprietary data from >100,000 fertility cycles to measure clinical outcomes and a reported 65% reduction in total per-pregnancy medical spend for participating employers, delivering ROI reports that show payback within 12–24 months for many clients.
By analyzing trends across thousands of cycles, Progyny refines its Smart Cycle care pathways and provides predictive insights—such as projected live-birth uplift and cost-per-live-birth—critical for CFOs and HR to justify the benefit.
Sales and Market Expansion
Progyny maintains continuous business development to win enterprise accounts and enter mid-market and public sectors, using conferences, webinars, and a 120-person direct sales force; by Q4 2025 cross-selling of integrated pharmacy and surrogacy increased deal value ~18% versus 2024.
- 120 reps direct sales
- 18% average deal-value uplift from cross-sell (Q4 2025)
- Targeting mid-market & public sector expansion
- Regular industry conferences & webinars
Technology Platform Development
Maintaining and upgrading Progyny’s digital infrastructure—member portal, provider claims interface, and employer benefits dashboard—is a continuous priority, with IT and R&D spending at $58M in FY2024 (12% of revenue) to support scalability.
Ongoing investment in telehealth and AI-driven tools—used in 35% of consultations in 2024—extends the advocacy model as membership grew 18% YoY to 165,000 members.
- Member portal, provider claims, employer dashboard maintained
- $58M IT/R&D spend in FY2024 (12% of revenue)
- Telehealth/AI used in 35% of consults (2024)
- Membership +18% YoY to 165,000 (2024)
Progyny: 165K members, 65% lower per-pregnancy cost, >75% SET, rapid ROI
Progyny runs a vetted provider network (SET >75%, multiple-births <5% vs US ~23% in 2024), Patient Care Advocates (20–30% higher success, 25% lower dropout; cost ~$1,200–$2,000/member), proprietary data from >100,000 cycles (65% reduction in per-pregnancy spend; ROI 12–24 months), $58M IT/R&D FY2024, telehealth/AI 35% consults, membership 165,000 (+18% YoY).
| Metric | Value |
|---|---|
| Members (2024) | 165,000 |
| IT/R&D (FY2024) | $58M |
| SET rate (2024) | >75% |
| Per-pregnancy spend ↓ | 65% |
Full Version Awaits
Business Model Canvas
The preview you see is the actual Progyny Business Model Canvas—not a mockup—and it’s the same document you’ll receive after purchase, ready for editing and presentation.
When you complete your order you’ll get this exact file in its full form, formatted and structured exactly as shown, with no hidden pages or filler content.
